Proteomic services for analysis of clinical samples

The Food and Drug Administration Office of Acquisition and Grant Services is seeking proteomic services for analysis of clinical samples under this solicitation notice. This procurement falls under the Research and Development in Biotechnology NAICS category and represents professional support services for the agency's analytical needs. The solicitation was posted on August 6, 2025, with responses due by August 20, 2025, providing potential contractors with a two-week window to prepare and submit their proposals. The government has attached a Notice of Intent (NOI.pdf) document that likely contains additional technical specifications and requirements for the proteomic analysis services. Evaluation criteria and specific contract requirements would be detailed in the attached government file, though these specifics are not provided in the basic solicitation notice.

This opportunity does not include any set-aside designations, making it open to competition from all eligible contractors regardless of business size or socioeconomic status. No information regarding potential incumbent contractors, specific award values, or budget ranges is provided in the basic solicitation details. The timeline for service delivery, quantity of clinical samples to be analyzed, and specific performance locations are not specified in this initial notice but would likely be contained within the attached NOI document. Contractors interested in this opportunity would need to review the government file to understand the full scope of work, technical requirements, and performance expectations. The specialized nature of proteomic services suggests this contract will require significant technical expertise and laboratory capabilities for clinical sample analysis.